---
layout: post
title: "Advisory Committee; Pharmaceutical Science and Clinical Pharmacology Advisory Committee, Renewal"
date: 2026-02-05 19:08:02 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2019-28530
original_published: 2020-01-06 00:00:00 +0000
significance: 8.00
---

# Advisory Committee; Pharmaceutical Science and Clinical Pharmacology Advisory Committee, Renewal

**Published:** February 05, 2026 19:08 UTC
**Source:** Federal Register
**Original Published:** January 06, 2020 00:00 UTC
**Document Number:** 2019-28530

## Summary

The Food and Drug Administration (FDA or Agency) is announcing the renewal of the Pharmaceutical Science and Clinical Pharmacology Advisory Committee by the Commissioner of Food and Drugs (the Commissioner). The Commissioner has determined that it is in the public interest to renew the Pharmaceutical Science and Clinical Pharmacology Advisory Committee for an additional 2 years beyond the charter expiration date. The new charter will be in effect until January 22, 2022.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2020/01/06/2019-28530/advisory-committee-pharmaceutical-science-and-clinical-pharmacology-advisory-committee-renewal)
- API: https://www.federalregister.gov/api/v1/documents/2019-28530

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
